EMJI – Emaji Inc. EMJI – Emaji

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Enhancing Healthcare Access Through Innovative Partnerships Rocket Doctor is soaring to new heights by partnering with a managed care plan in California. This collaboration aims to serve nearly half a million Medicaid members, a significant accomplishment that represents Rocket Doctor’s commitment to improving healthcare accessibility. Understanding the Partnership...

Texas Instruments Launches GaN Chip Production Expansion Texas Instruments (TI) (NASDAQ: TXN) has taken a significant step towards enhancing its semiconductor manufacturing capabilities by starting production of gallium nitride (GaN)-based power semiconductors at its facility in Aizu, Japan. This development marks a crucial milestone for the company as it increases its...

Sport Clips Haircuts Announces National Signing Days Sport Clips Haircuts, the leading franchise dedicated to grooming men and boys, is excited to host National Signing Days on October 28 and 29. During these special days, qualified stylists will have the unique opportunity to attend guaranteed interviews and possibly receive instant job offers. This initiative aims to...

Enhance Your Holiday Season with Yaber Projectors This holiday season, Yaber invites you to elevate your Christmas experiences with its state-of-the-art projectors. These projectors are now available at fantastic discounts, making it easy to create memorable moments for family gatherings, cozy movie nights, and thoughtful gifts. Transform Your Space into a Winter...

Citi Maintains Buy Rating on Huntington Bancshares Citi has reaffirmed its Buy rating on Huntington Bancshares (NASDAQ: HBAN) while maintaining a price target of $18.00. This decision follows the company's recent earnings report for the third quarter, where the bank showed resilience and effective financial management. The firm has opted to remove the previous positive...